# Sapient Capital Management

> Sapient Capital Management is a VC fund in Wilson backing Health Care and Medical Device. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Wilson, United States
- Total investments: 3
- Last investment: Apr 2010
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.sapientcapital.com

Sapient Capital Management is a VC fund in Wilson focused on Health Care and Medical Device. Sapient Capital is a venture capital fund formed to help visionary entrepreneurs and executives build value in new healthcare related businesses. The fund is focused exclusively on healthcare, with an emphasis on medical device firms targeting novel solutions to satisfy large unmet medical needs.Capitalized at $26 million, Sapient Capital ispartnering with a select group of innovative companies. Sapient Capital focuses on seed, start-up and early stage companies. In addition, the fund will make private equity investments in healthcare related companies that are already public, as long as their market capitalizations are under $150 million.Sapient Capital is a member of the National Venture Capital Association (NVCA).

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 100% |
| Medical Device | 3 | 100% |
| Medical | 1 | 33% |
| Manufacturing | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Series C | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Hemosphere | Hemosphere developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft, a proprietary graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction. | $9.3M | Series A | Apr 07, 2010 |  |
| ValenTx | ValenTx is a development-stage medical device company that focuses on minimally-invasive methods for the treatment of morbid obesity. The company was founded in 2002 and headquartered in Maple Grove, Minnesota. | $22M | Series B | Sep 08, 2009 |  |
| Arbor Surgical Technologies | Arbor Surgical Technologies, Inc. located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential todeliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. | $20M | Series C | Jan 30, 2008 |  |

3 of 3 investments shown.

## Co-investors
- [Kaiser Permanente Ventures](https://shizune.co/investors/profile/kaiser-permanente-ventures) — VC Fund, 3 deals together
- [Affinity Capital Management](https://shizune.co/investors/profile/affinity-capital-management) — VC Fund, 2 deals together
- [Three Arch Partners](https://shizune.co/investors/profile/three-arch-partners) — VC Fund, 2 deals together
- [Alloy Ventures](https://shizune.co/investors/profile/alloy-ventures) — VC Fund, 1 deal together
- [Ascension Ventures](https://shizune.co/investors/profile/ascension-ventures) — VC Fund, 1 deal together
- [Baird Capital](https://shizune.co/investors/profile/baird-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Sapient Capital Management invest in?

Sapient Capital Management invests primarily in Health Care, Medical Device and Medical startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Sapient Capital Management last invest?

The most recent investment recorded for Sapient Capital Management closed in Apr 2010. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co